Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeiger Counter Regulatory News (GCL)

Share Price Information for Geiger Counter (GCL)

Share Price is delayed by 15 minutes
Get Live Data
72.80    2.20 (3.13%)
Bid:
71.00
Ask:
74.60
Spread: 3.60 (5.07%)
Market Cap: £91.33m
GCL Live PriceLast checked at - London Stock Exchange

Intraday Geiger Counter Share Chart

Notice of GM - 7 August 2025

21 Jul 2025 07:00

RNS Number : 6474R
Geiger Counter Ltd
21 July 2025
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, TO US PERSONS OR INTO OR WITHIN THE UNITED STATES, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN, OR ANY OTHER JURISDICTION WHERE, OR TO ANY OTHER PERSON TO WHOM, TO DO SO WOULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER TO SELL OR ISSUE, OR ANY SOLICITATION OF ANY OFFER TO PURCHASE, SUBSCRIBE FOR OR OTHERWISE ACQUIRE, ANY INVESTMENTS IN ANY JURISDICTION

21 July 2025

 

GEIGER COUNTER LIMITED ("GCL" OR THE "COMPANY")

Proposals to renew the authority to the Company to make market purchases of its own ordinary shares in the capital of the Company

The Board of Geiger Counter Limited today announces the publication of a circular (the "Circular") proposing a renewal of the authority provided to the Directors on 5 March 2025 to make market purchases of its own ordinary shares in the capital of the Company.

Unless otherwise defined, capitalised terms used in this announcement shall have the same meaning as set out in the Circular.

Background to Proposal

At the Company's annual general meeting on 5 March 2025 (the 2025 AGM), Shareholders granted authority to the Directors to make market purchases of up to 20,016,102 ordinary shares in the capital of the Company (Ordinary Shares) representing 14.99 per cent. of the then issued ordinary share capital (excluding treasury shares).

 

As at 17 July 2025, the Company has bought back 17,350,950 Ordinary Shares and the authority granted at the 2025 AGM has been substantially utilised, representing an 86.7 per cent utilisation. If buybacks were to continue at the same rate as they have since the 2025 AGM, the remaining buyback capacity would be fully utilised before the Company's next annual general meeting (the 2026 AGM), which is expected to be held on 5 March 2026. The Directors therefore wish to seek a more immediate approval for a renewal of this authority.

 

The Board believes it is important to continue to have the flexibility to buy back Ordinary Shares with the objective of controlling the discount level. Accordingly, the Directors monitor the share price of the Company closely and in normal market conditions use the authority granted to them to make market purchases of Ordinary Shares when they believe it is in the best interests of Shareholders to do so and to ensure that the share price does not reach an excessive discount.

 

 

Recommendation

The Directors consider the passing of the resolution to be in the best interests of the Company and its Shareholders as a whole. Accordingly, the Directors unanimously recommend that Shareholders vote in favour of the resolution.

The Directors intend to vote in favour of the resolution in respect of their own beneficial holdings of Ordinary Shares, amounting to 364,296 Ordinary Shares (representing approximately 0.31 per cent of the issued share capital of the Company (excluding treasury shares) as at the date of the Circular).

General Meeting

The Proposals are subject to Shareholder approval. The notice convening the General Meeting, to be held at 11.00 a.m. on 7 August 2025 at the registered office address of the Company, Ordnance House, 31 Pier Road, St Helier, Jersey JE4 8PW, is set out in the Circular. The notice includes the full text of the Resolutions.

The expected timetable of principal events in relation to the General Meeting is as follows:

Publication of this Circular and the Notice of General Meeting

21 July 2025

 

Latest time and date for receipt of Forms of Proxy for use at the General Meeting

 

 

4.00 p.m. on 5 August 2025

General Meeting

 

11.00 a.m. on 7 August 2025

Results of the General Meeting announced

 

7 August 2025

The times and dates set out in the timetable above and mentioned throughout this Circular are indicative only and may be adjusted by the Company without further notice. Any changes will be notified to Shareholders through an RNS. References to times in this Circular are to Jersey time (BST) unless otherwise stated.

 

A copy of the Circular will be made available on the Company's website NCIM - Geiger Counter Ltd - Fund Page for Geiger Counter Ltd and submitted to the National Storage Mechanism, where it will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

 

 

Enquiries

Manulife | CQS

Craig Cleland

T: +44 (0) 20 7201 5368

 

Cavendish Capital Markets Limited

Tunga Chigovanyika (Corporate Finance)

 

T: +44 (0) 20 7220 0557

Daniel Balabanoff / Pauline Tribe (Sales)

 

T: +44 (0) 20 7220 0500

R&H Fund Services (Jersey) Limited

Jane De Barros

T :+44 (0) 1534 825 259

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOGGLGDRXBBDGUI
Date   Source Headline
3rd Jun 202612:22 pmRNSNet Asset Value(s)
2nd Jun 20262:04 pmRNSAppointment of Non-Executive Director
2nd Jun 20261:23 pmRNSNet Asset Value(s)
1st Jun 202612:24 pmRNSNet Asset Value(s)
29th May 20261:30 pmRNSNet Asset Value(s)
28th May 20263:31 pmRNSNet Asset Value(s)
27th May 20264:23 pmRNSNet Asset Value(s)
27th May 202611:57 amRNSMonthly Factsheet - April 2026
26th May 20265:24 pmRNSNet Asset Value(s)
22nd May 20262:06 pmRNSNet Asset Value(s)
21st May 20261:09 pmRNSNet Asset Value(s)
20th May 20263:20 pmRNSNet Asset Value(s)
19th May 20263:08 pmRNSNet Asset Value(s)
18th May 20261:36 pmRNSNet Asset Value(s)
15th May 20264:29 pmRNSPortfolio Management Update
15th May 20262:08 pmRNSNet Asset Value(s)
15th May 202612:42 pmRNSDistribution of Rump proceeds
14th May 20262:50 pmRNSNet Asset Value(s)
13th May 20262:19 pmRNSNet Asset Value(s)
13th May 20261:50 pmRNSHolding(s) in Company
12th May 20263:56 pmRNSHolding(s) in Company
12th May 20263:35 pmRNSDirector/PDMR Shareholding
12th May 20263:28 pmRNSNet Asset Value(s)
11th May 20262:45 pmRNSNet Asset Value(s)
8th May 20263:20 pmRNSNet Asset Value(s)
7th May 20264:28 pmRNSNet Asset Value(s)
7th May 20268:55 amRNSSubscription Rights Rump Placing
6th May 20265:19 pmRNSNet Asset Value(s)
6th May 20267:40 amRNSSubscription Rights for 2027
6th May 20267:28 amRNSSubscription Rights Results 2026
5th May 20264:50 pmRNSNet Asset Value(s)
1st May 20263:14 pmRNSNet Asset Value(s)
30th Apr 20264:08 pmRNSNet Asset Value(s)
29th Apr 20263:00 pmRNSNet Asset Value(s)
28th Apr 20262:52 pmRNSNet Asset Value(s)
28th Apr 202610:10 amRNS-RUpdate research from QuotedData
27th Apr 20262:55 pmRNSNet Asset Value(s)
24th Apr 20262:58 pmRNSNet Asset Value(s)
23rd Apr 20262:55 pmRNSNet Asset Value(s)
23rd Apr 202610:09 amRNSMonthly Factsheet- March 2026
22nd Apr 20261:38 pmRNSNet Asset Value(s)
21st Apr 20262:55 pmRNSNet Asset Value(s)
20th Apr 202612:20 pmRNSNet Asset Value(s)
17th Apr 20263:29 pmRNSNet Asset Value(s)
16th Apr 20262:35 pmRNSNet Asset Value(s)
16th Apr 202610:41 amRNSDirectors intent re subscription rights
15th Apr 20261:29 pmRNSNet Asset Value(s)
14th Apr 20261:11 pmRNSNet Asset Value(s)
14th Apr 20267:52 amRNSNet Asset Value(s)
10th Apr 20261:55 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.